Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma.

Cancer medicine - 1 Nov 2021

Bastos-Oreiro Mariana, Ortiz Javier, Pradillo Virginia, Salas Eduardo, Marínez-Laperche Carolina, Muñoz Andrés, Buño Ismael, Diéz-Martin José Luis, Soria Jose Manuel, Pascual Izquierdo Cristina

Abstract excerpt

BACKGROUND: The incorporation of genetic variables into risk scores for predicting venous thromboembolic events (VTE) could improve their capacity to identify those patients for whom thromboprophylaxis would be most beneficial. Proof-of-concept of this is provided by the TiC-ONCO score for predicting the risk of VTE in patients with solid tumours. Our aim was to develop a similarly improved tool-the TiC-LYMPHO...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Anticoagulants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hodgkin Disease

Share to Lymphoma, Non-Hodgkin

Share to Predictive Value of Tests

Share to Proof of Concept Study

Share to Risk Assessment

Share to Venous Thromboembolism

Source

Open in PubMed Open full text

Identifiers

PMID: 34598309
DOI: 10.1002/cam4.4280
PMCID: PMC8559493

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma.PMID 34598309Read ↗

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.Semantic proximity Read ↗

Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort studySemantic proximity Read ↗

[The genetics of thrombosis in cancer].Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer.Semantic proximity Read ↗

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients.Semantic proximity Read ↗

Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?Semantic proximity Read ↗

Potential utility of comprehensive genomic profiling to predict venous thromboembolism in patients with solid cancer.Semantic proximity Read ↗

Prediction of primary venous thromboembolism based on clinical and genetic factors within the U.K. Biobank.Semantic proximity Read ↗

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocolSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.